| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -16,370 | -17,982 | -18,089 | -16,673 |
| Net loss per common share, basic (in usd per share) | -0.36 | -0.4 | -0.4 | -0.38 |
| Net loss per common share, diluted (in usd per share) | -0.36 | -0.4 | -0.4 | -0.38 |
| Weighted-average common shares outstanding, basic (in shares) | 45,804,042 | 44,981,746 | 44,827,159 | 43,704,836 |
| Weighted-average common shares outstanding, diluted (in shares) | 45,804,042 | 44,981,746 | 44,827,159 | 43,704,836 |
Werewolf Therapeutics, Inc. (HOWL)
Werewolf Therapeutics, Inc. (HOWL)